Poster discussion
New insights into exercise and muscle performance
Chairs
M. Steiner
Leicester (Leicestershire)
(United Kingdom)
Comparison of 2- versus 6-minute walking test in patients with severe COPD
R. Gloeckl(Schoenau am Koenigssee, Germany)
COI
1
Responsiveness of the short physical performance battery (SPPB) in severely dyspnoeic patients with COPD
D. Carrington(Middlesex, United Kingdom)
COI
2
Compartments distribution of body composition in patients with chronic obstructive pulmonary disease
J. De Brito Jardim(São Paulo (SP), Brazil)
COI
3
Reliability and validity of the modified stair climb power test in COPD
S. Jones(Berkshire, United Kingdom)
COI
4
The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments
H. Kano(Ogaki, Japan)
COI
5
Can diagnostic staff (DS) or patients predict whether the 6-minute walk distance (6MWD) will improve to a relevant extent at a repeated 6-minute walk test (R-6MWT)?
S. Wingart(Bad Reichenhall, Germany)
COI
6
Multi-frequency bioelectric impedance ratio and physical performance in stable COPD
J. Canavan(Bedford, United Kingdom)
COI
7
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
S. Kon(Middlesex, United Kingdom)
COI
8
Muscle power output in older adults with COPD
L. Saez De Asteasu(Alsasua, Spain)
COI
9
Acute impact of percutaneous electrical stimulation (PES) & resistance exercise (RE) on quadriceps muscle gene expression in COPD
L. Latimer(Rugby (Warwickshire), United Kingdom)
COI
10
Determinants of rapid exercise capacity decline in patients with COPD
S. Crook(Zürich, Switzerland)
COI
11
COPD and oxygen supplementation: Improvement in inspiratory capacity and dyspnea during exercise
L. Vesteng(Jessheim, Norway)
COI
12
Reactive oxygen species regulate autophagy in COPD myotubes in vitro
P. Pomiès(Montpellier Cedex 5, France)
COI
13
Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation
C. De Theije(Maastricht, Netherlands)
COI
14
Inactivation of glycogen synthase kinase-3 is not required for recovery of muscle mass of disuse-atrophied muscle
R. Langen(Maastricht, Netherlands)
COI
15
Aerobic exercise reduces lung inflammation and fibrosis mediated by serotoninergic/Akt signaling in a model of pulmonary fibrosis
R. P Vieira(Anápolis, Brazil)
COI
16
The role of growth and differentiation factor 15 (GDF-15) in the development of skeletal muscle wasting in pulmonary arterial hypertension (PAH)
B. Garfield(London, United Kingdom)
COI
17
Aerobic exercise reduces pulmonary inflammation in diet-induced obesity in a HDM model of asthma through adipokines, IL-10, IL-17 and IL-23 signaling
J. Comin(Sao Bernardo Do Campo (SP), Brazil)
COI
18
. . .